BOOKMARK
  • Korean|
  • Chinese|
  • Japanese|
  • Vietnamese
본문내용 바로가기

Aju Business Daily

SEARCH
  • ECONOMY
  • ENTERTAINMENT
  • IT
  • South Korea
  • North Korea
  • WORLD
  • SPORTS
  • LIFESTYLE
  • AUTO MOTIVE
  • OPINION
  • PEOPLE
  • MILITARY
Home > Health > article

S. Korea approves acquisition of COVID-19 vaccines for 60 % of entire population

Lim Chang-won Reporter(cwlim34@ajunews.com) | Posted : September 15, 2020, 10:55 | Updated : September 15, 2020, 11:28
  • 트위터
  • 페이스북
  • 웨이보

[Yonhap Photo]

SEOUL -- The South Korean government approved the proposed acquisition of COVID-19 vaccines that can inoculate some 30 million people or 60 percent of the entire population through cooperation with an international body or foreign companies while accelerating the independent development of effective vaccines.

In a cabinet meeting chaired by Prime Minister Chung Sye-kyun, the government decided to acquire vaccines for 10 million people through COVAX Facility, an international organization created to guarantee quick and equitable access to COVID-19 vaccines throughout the world, as well as vaccines for 20 million people through foreign companies.

"We want to secure enough supplies to inoculate all of the people, but there is still a limit to investing recklessly because the safety and effectiveness of vaccines, as well as the success of vaccine development, is uncertain," Chung said, calling for a "proactive and strategic" approach.

South Korea has sent an application to participate in COVAX Facility. The advance payment for the acquisition of vaccines will be made by October 9. Chung said the government would provide full support for the development of vaccines at home.

South Korea has unveiled a roadmap for the treatment of COVID-19 to develop plasma treatment by the year's end as well as antibody treatment and vaccines next year. The government would preferentially vaccinate health officials, workers at essential social facilities, soldiers, old people and those suffering from chronic disease.

Sugentech, an in-vitro diagnostic test reagent producer in South Korea, started selling its rapid test kit called "IVnAT" that can examine the immune status of people carrying COVID-19 antibodies in two hours. Antibody test kits are useful in confirming the efficacy of vaccines.

  • Lim Chang-won Reporter
  • email : cwlim34@ajunews.com
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.
  • twitter
  • facebook
  • weibo
  • link copy
  • LIST
  • TOP

Related news

  • .Semiconductor-based fast test kit using saliva able to debut in March: science minister.
    Semiconductor-based fast test kit using saliva able to debut…
  • .Syringes for COVID-19 vaccines added to list of K-quarantine technologies.
    Syringes for COVID-19 vaccines added to list of 'K-quarantin…
  • .Health officials heave sigh of relief at early introduction of Novavax vaccine .
    Health officials heave sigh of relief at early introduction …
  • .Bukwangs COVID-19 treatment wins FDA approve to go ahead with second-phase clinical trials.
    Bukwang's COVID-19 treatment wins FDA approve to go ahead wi…
  • .Experts give conditional consent to AstraZenecas vaccine for people over 65.
    Experts give conditional consent to AstraZeneca's vaccine fo…

Real Time Photo News

  • .BTS agency posts record earnings in 2020 on brisk online activities and album sales .

    BTS agency posts record earnings in 2020 on brisk online activities and album sales

  • .[FOCUS] BTS agency leagues with Universal Music to launch new K-pop band in US music scene.

    [FOCUS] BTS agency leagues with Universal Music to launch new K-pop band in US music scene

  • .CJ ENM aims to become major visual content producer thru partnership with Epic Games .

    CJ ENM aims to become major visual content producer thru partnership with Epic Games

  • .​Solo singer Sunmi to come back with new album Tail.

    ​Solo singer Sunmi to come back with new album 'Tail'

  • .Big Hits live-streaming joint venture gains reinforcements from Universal Music, YG.

    Big Hit's live-streaming joint venture gains reinforcements from Universal Music, YG

Latest News

more+

  • Prime Minister Chung stresses importance of 'borderless communication channel' to minimize informati…
  • State hospital succeeds in inserting wireless pacemakers into hearts of bradyarrhythmia patients
  • LG Electronics' joint venture with Canada's Magna awaits approval by shareholders in March
  • Sajo Seafood to launch raw tuna menu delivery service
  • Researchers find new roundworm species near Dokdo
Aju Business Daily
  • ABOUT US
  • CONTACT US
  • PRIVACY STATEMENT
  • Copyright Policy

Address : Aju News Corporation LEEMA Building, 11th floor, 42, Jong-ro 1-gil, Jongno-gu, Seoul.    Mail : swatchsjp@ajunews.com

Copyright ⓒ 2016 By Ajunews Corporation, All Rights Reserved.

Mobile view